+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Altrenogest Market by Animal Type (Equine, Swine), Product Form (Feed Additive, Oral Gel), Distribution Channel, End User, Product Type - Global Forecast 2025-2030- Product Image
Altrenogest Market by Animal Type (Equine, Swine), Product Form (Feed Additive, Oral Gel), Distribution Channel, End User, Product Type - Global Forecast 2025-2030- Product Image
Sale

Altrenogest Market by Animal Type (Equine, Swine), Product Form (Feed Additive, Oral Gel), Distribution Channel, End User, Product Type - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 195 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6155406
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Setting the Stage for Understanding Altrenogest’s Role in Modern Animal Reproductive Health Management Across Equine and Swine Industries

Altrenogest stands as a cornerstone in reproductive management protocols for equine and swine industries, offering reliable efficacy in estrus synchronization and pregnancy maintenance. Derived from progestin compounds, this veterinary pharmaceutical has earned widespread adoption due to its ability to streamline breeding programs, improve reproductive efficiency, and optimize overall herd performance. In equine applications, its precise dosing regimens help trainers and breeders achieve more predictable foaling schedules, while swine producers leverage its oral formulations to enhance gilt development and sow fertility.

In recent years, the growing demand for sustainable livestock production has amplified interest in hormone-based interventions that can reduce the environmental footprint of animal husbandry. At the same time, stakeholders across veterinary clinics and breeding farms seek solutions that deliver consistent results without compromising animal welfare. Consequently, Altrenogest’s market relevance has intensified as industry players balance the imperatives of biosecurity, productivity, and economic viability. This report sets the stage by exploring foundational aspects of the molecule, user needs, and evolving expectations among veterinarians and farm managers alike.

Recognizing Pivotal Shifts Driven by Technological Innovations Regulatory Trends and Sustainability Imperatives Reshaping the Altrenogest Market Landscape

The Altrenogest landscape is undergoing transformative shifts driven by advances in formulation science, evolving regulatory frameworks, and mounting sustainability pressures. Recent breakthroughs in controlled-release technologies have paved the way for next-generation feed additives and oral gels that extend release profiles, reduce dosing frequency, and enhance palatability for target species. Moreover, digital dosing platforms are emerging that track consumption in real time, offering veterinarians and producers unprecedented monitoring capabilities.

Regulatory bodies in major markets are recalibrating guidelines to tighten residue limits and reinforce compliance protocols, prompting manufacturers to invest in robust safety data packages and transparent supply chain audits. At the same time, industry alliances are advocating for harmonized standards across regions to reduce market entry barriers and streamline approvals. Sustainability initiatives, driven by consumer demand for ethically sourced animal products, are also reshaping product development priorities. Consequently, companies are exploring plant-based or minimally processed excipients, while partners across the value chain collaborate on carbon footprint reduction strategies. These converging dynamics are redefining how Altrenogest products are formulated, marketed, and integrated into complex veterinary workflows.

Assessing the Multi-Faceted Effects of 2025 United States Tariff Increases on Altrenogest Supply Chains Pricing and Procurement Dynamics

The cumulative impact of United States tariffs announced for 2025 has reverberated throughout the global Altrenogest supply chain, significantly altering cost structures and procurement strategies. Increased import duties on active pharmaceutical ingredients have driven up raw material expenses for manufacturers, compelling many to reevaluate sourcing strategies and negotiate longer-term contracts to mitigate volatility. In response, a number of suppliers have shifted towards regional production hubs or partnered with contract development and manufacturing organizations to localize supply, thereby reducing exposure to U.S.-imposed duties.

These adjustments have, in turn, affected pricing for end users, leading veterinary distributors and clinics to absorb, defer, or negotiate incremental cost pass-throughs. Some larger breeding farm operations have turned to forward purchasing agreements to lock in supply ahead of anticipated tariff increases, while smaller practices face tighter margins and intensified pressure to justify premium pricing. Throughout this period, transparency in cost decomposition and traceability has emerged as a critical differentiator among manufacturers, fostering greater collaboration between suppliers, regulatory agencies, and purchasers seeking clarity on tariff-related line items.

Unveiling Detailed Segmentation Patterns Across Animal Type Product Form Distribution Channels End Users and Product Variants

A nuanced examination of market segmentation underscores the diverse applications and delivery mechanisms driving Altrenogest adoption. Segmentation based on animal type reveals two primary submarkets: equine contexts that prioritize controlled breeding schedules for performance and lineage management, and swine operations focused on gilt development and litter uniformity. Within the categorization by product form, the landscape further branches into feed additives and oral gels, with feed additives distinguished by pellet and powder presentations intended to meet specific handling preferences and nutritional protocols.

Distribution channels reflect varying degrees of direct engagement and digital integration, spanning direct sales pipelines, online platforms for streamlined ordering, and established veterinary distributors that offer consultative services. End users encompass breeding farms-both equine and swine facilities that demand scalable solutions to optimize profitability-as well as veterinary clinics, from large animal hospitals with integrated surgical and reproductive services to private practices emphasizing personalized animal care. Finally, product type differentiates branded formulations backed by robust safety and efficacy claims from generic offerings that appeal to cost-sensitive buyers seeking comparable performance at a lower price point.

Exploring Unique Regional Drivers Regulatory Landscapes and Adoption Trends in the Americas EMEA and Asia-Pacific Markets

Geographic insights reveal distinct dynamics across three major regions, each with unique demand drivers and regulatory environments. In the Americas, growth has been propelled by robust breeding farm expansions and a well-established veterinary distribution network that supports both branded and generic formulations. Heightened focus on genetic improvement programs in North America has driven premium uptake, while South American markets increasingly prioritize cost-efficient generics to support large-scale swine production.

In Europe, Middle East and Africa, stringent regulatory oversight and residue monitoring programs are shaping product registrations and labeling requirements. Breeding operations in Western Europe emphasize traceability and eco-friendly manufacturing, whereas emerging markets in the Middle East and Africa show growing receptivity to oral gel formats tailored for smallholder breeders seeking simplified dosing. Across the Asia-Pacific, rapid modernization of swine facilities in China and Southeast Asia has fueled adoption of both pellet and powder feed additives, while expanding veterinary infrastructure in Australia and Japan drives demand for advanced gel formulations supported by clinical research data.

Highlighting Strategic Alliances Technological Partnerships and Competitive Positioning among Leading Altrenogest Manufacturers

A survey of key competitive players highlights strategic initiatives and innovation pipelines shaping the Altrenogest arena. Leading pharmaceutical firms have intensified R&D collaborations with contract manufacturers to develop extended‐release formulations that differentiate their branded portfolios. Partnerships with veterinary technology startups are fostering digital monitoring solutions that integrate dosing data with herd management platforms, enhancing product value propositions.

Meanwhile, generic drug manufacturers are leveraging streamlined production footprints in cost-advantaged regions to offer price-competitive alternatives that maintain bioequivalence standards. Several mid-sized companies are carving niches by focusing on specialized end-user segments, such as boutique equine practices or large-scale incubators in emerging markets, tailoring packaging sizes and educational resources to local needs. Collectively, these strategic moves underscore a balancing act between innovation leadership and operational efficiency, with each player seeking to capture value through differentiated offerings and agile supply chain execution.

Advocating Proactive Supply Chain Optimization Regulatory Collaboration and Innovation Investments to Drive Competitive Advantage

Industry leaders should prioritize supply chain diversification to safeguard against tariff volatility and regulatory shifts. Investing in regional manufacturing hubs or local contract partnerships can mitigate import-related cost pressures while enhancing responsiveness to evolving compliance standards. Moreover, dedicating resources to formulation breakthroughs-such as slow-release excipient research-will strengthen product differentiation in both feed additive and oral gel segments.

Engaging proactively with regulatory authorities through joint research initiatives and transparent data-sharing can expedite approvals and foster goodwill, particularly in regions with stringent residue monitoring. At the same time, forging alliances with digital health providers can yield integrated solutions that combine dosing analytics with herd management insights, thereby elevating the value proposition for end users. Finally, anchoring sustainability goals within product roadmaps-by sourcing eco-friendly excipients and optimizing carbon footprints-will resonate with ethically conscious breeders and veterinarians, securing long-term market advantage.

Detailing Our Comprehensive Mixed-Methods Research Approach Incorporating Stakeholder Interviews Regulatory Analysis and Data Triangulation

This research integrates a rigorous combination of primary and secondary methodologies to ensure comprehensive market insights. Primary research encompassed structured interviews with veterinarians, breeding farm operators, and distribution executives to capture operational challenges, product preferences, and procurement trends. Supplementary expert roundtables provided qualitative depth on emerging regulatory requirements and technological adoption patterns.

Secondary data sources included regulatory filings, industry white papers, and conference proceedings to validate market developments and formulation advancements. Quantitative data points were triangulated through cross-referencing import-export statistics, patent filings, and company financial disclosures. Throughout the process, a multilayered quality assurance framework was applied, involving data validation checks, peer reviews by domain specialists, and scenario modeling to stress-test key assumptions. This methodological rigor underpins the report’s reliability, ensuring that strategic recommendations align with current and forecasted industry trajectories.

Concluding Insights Emphasizing the Imperative of Agility Innovation and Sustainability for Future Success in the Altrenogest Market

In conclusion, Altrenogest remains an indispensable tool in reproductive management across equine and swine sectors, bolstered by advances in formulation science, evolving regulatory landscapes, and a growing emphasis on sustainable practices. The 2025 tariff shifts have underscored the importance of supply chain agility and cost transparency, while diverse segmentation and regional dynamics highlight opportunities for targeted innovation. Competitive players continue to pursue differentiated offerings through R&D collaborations and digital integration, setting new benchmarks in product value. By adhering to the strategic recommendations outlined-spanning supply chain resilience, regulatory engagement, and sustainability focus-industry stakeholders can navigate current challenges and position themselves for sustained growth in a rapidly evolving market environment.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Animal Type
    • Equine
    • Swine
  • Product Form
    • Feed Additive
      • Pellet
      • Powder
    • Oral Gel
  • Distribution Channel
    • Direct Sales
    • Online
    • Veterinary Distributor
  • End User
    • Breeding Farms
      • Equine Farms
      • Swine Farms
    • Veterinary Clinics
      • Large Animal Hospitals
      • Private Practices
  • Product Type
    • Branded
    • Generic
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report delves into recent significant developments and analyzes trends in each of the following companies:
  • Merck & Co., Inc.
  • Zoetis Inc.
  • Elanco Animal Health Incorporated
  • Boehringer Ingelheim International GmbH
  • Ceva Santé Animale S.A.
  • Vetoquinol S.A.
  • Virbac S.A.
  • Norbrook Laboratories Limited
  • Dechra Pharmaceuticals PLC

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Growing adoption of generic altrenogest formulations leading to price competition and margin pressure in equine reproductive management
5.2. Emergence of novel sustained-release altrenogest delivery systems to improve dosing accuracy and animal welfare compliance
5.3. Regulatory shifts in Europe and Asia-Pacific driving approval timelines and market access for altrenogest products in livestock
5.4. Integration of digital health monitoring tools with altrenogest treatment protocols enhancing fertility outcome predictability in mares
5.5. Increasing demand for high-quality altrenogest from the global equine breeding industry fueling capacity expansions in key manufacturing sites
5.6. Advancements in green chemistry processes for eco-friendly altrenogest synthesis addressing sustainability mandates by major pharmaceutical companies
5.7. Strategic partnerships between veterinary pharmaceutical players and contract manufacturers to mitigate altrenogest supply chain disruptions
5.8. Clinical research on combination therapies of altrenogest with GnRH analogs boosting efficacy in sow reproductive performance
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Altrenogest Market, by Animal Type
8.1. Introduction
8.2. Equine
8.3. Swine
9. Altrenogest Market, by Product Form
9.1. Introduction
9.2. Feed Additive
9.2.1. Pellet
9.2.2. Powder
9.3. Oral Gel
10. Altrenogest Market, by Distribution Channel
10.1. Introduction
10.2. Direct Sales
10.3. Online
10.4. Veterinary Distributor
11. Altrenogest Market, by End User
11.1. Introduction
11.2. Breeding Farms
11.2.1. Equine Farms
11.2.2. Swine Farms
11.3. Veterinary Clinics
11.3.1. Large Animal Hospitals
11.3.2. Private Practices
12. Altrenogest Market, by Product Type
12.1. Introduction
12.2. Branded
12.3. Generic
13. Americas Altrenogest Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Altrenogest Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Altrenogest Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Merck & Co., Inc.
16.3.2. Zoetis Inc.
16.3.3. Elanco Animal Health Incorporated
16.3.4. Boehringer Ingelheim International GmbH
16.3.5. Ceva Santé Animale S.A.
16.3.6. Vetoquinol S.A.
16.3.7. Virbac S.A.
16.3.8. Norbrook Laboratories Limited
16.3.9. Dechra Pharmaceuticals PLC
17. Research AI18. Research Statistics19. Research Contacts20. Research Articles21. Appendix
List of Figures
FIGURE 1. ALTRENOGEST MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL ALTRENOGEST MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL ALTRENOGEST MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL ALTRENOGEST MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL ALTRENOGEST MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL ALTRENOGEST MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ALTRENOGEST MARKET SIZE, BY PRODUCT FORM, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ALTRENOGEST MARKET SIZE, BY PRODUCT FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ALTRENOGEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ALTRENOGEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ALTRENOGEST MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ALTRENOGEST MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL ALTRENOGEST MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL ALTRENOGEST MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS ALTRENOGEST MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS ALTRENOGEST MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES ALTRENOGEST MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES ALTRENOGEST MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ALTRENOGEST MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ALTRENOGEST MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC ALTRENOGEST MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC ALTRENOGEST MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ALTRENOGEST MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. ALTRENOGEST MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. ALTRENOGEST MARKET: RESEARCHAI
FIGURE 26. ALTRENOGEST MARKET: RESEARCHSTATISTICS
FIGURE 27. ALTRENOGEST MARKET: RESEARCHCONTACTS
FIGURE 28. ALTRENOGEST MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. ALTRENOGEST MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ALTRENOGEST MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL ALTRENOGEST MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL ALTRENOGEST MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL ALTRENOGEST MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL ALTRENOGEST MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL ALTRENOGEST MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL ALTRENOGEST MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL ALTRENOGEST MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL ALTRENOGEST MARKET SIZE, BY EQUINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL ALTRENOGEST MARKET SIZE, BY EQUINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL ALTRENOGEST MARKET SIZE, BY SWINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL ALTRENOGEST MARKET SIZE, BY SWINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL ALTRENOGEST MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL ALTRENOGEST MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL ALTRENOGEST MARKET SIZE, BY FEED ADDITIVE, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL ALTRENOGEST MARKET SIZE, BY FEED ADDITIVE, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL ALTRENOGEST MARKET SIZE, BY PELLET, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL ALTRENOGEST MARKET SIZE, BY PELLET, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL ALTRENOGEST MARKET SIZE, BY POWDER, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL ALTRENOGEST MARKET SIZE, BY POWDER, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL ALTRENOGEST MARKET SIZE, BY FEED ADDITIVE, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL ALTRENOGEST MARKET SIZE, BY FEED ADDITIVE, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL ALTRENOGEST MARKET SIZE, BY ORAL GEL, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL ALTRENOGEST MARKET SIZE, BY ORAL GEL, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL ALTRENOGEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL ALTRENOGEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL ALTRENOGEST MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL ALTRENOGEST MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL ALTRENOGEST MARKET SIZE, BY ONLINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL ALTRENOGEST MARKET SIZE, BY ONLINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL ALTRENOGEST MARKET SIZE, BY VETERINARY DISTRIBUTOR, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL ALTRENOGEST MARKET SIZE, BY VETERINARY DISTRIBUTOR, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL ALTRENOGEST MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL ALTRENOGEST MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL ALTRENOGEST MARKET SIZE, BY BREEDING FARMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL ALTRENOGEST MARKET SIZE, BY BREEDING FARMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL ALTRENOGEST MARKET SIZE, BY EQUINE FARMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL ALTRENOGEST MARKET SIZE, BY EQUINE FARMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL ALTRENOGEST MARKET SIZE, BY SWINE FARMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL ALTRENOGEST MARKET SIZE, BY SWINE FARMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL ALTRENOGEST MARKET SIZE, BY BREEDING FARMS, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL ALTRENOGEST MARKET SIZE, BY BREEDING FARMS, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL ALTRENOGEST MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL ALTRENOGEST MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL ALTRENOGEST MARKET SIZE, BY LARGE ANIMAL HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL ALTRENOGEST MARKET SIZE, BY LARGE ANIMAL HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL ALTRENOGEST MARKET SIZE, BY PRIVATE PRACTICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL ALTRENOGEST MARKET SIZE, BY PRIVATE PRACTICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL ALTRENOGEST MARKET SIZE, BY VETERINARY CLINICS, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL ALTRENOGEST MARKET SIZE, BY VETERINARY CLINICS, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL ALTRENOGEST MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL ALTRENOGEST MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL ALTRENOGEST MARKET SIZE, BY BRANDED, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL ALTRENOGEST MARKET SIZE, BY BRANDED, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL ALTRENOGEST MARKET SIZE, BY GENERIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL ALTRENOGEST MARKET SIZE, BY GENERIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. AMERICAS ALTRENOGEST MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 60. AMERICAS ALTRENOGEST MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 61. AMERICAS ALTRENOGEST MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 62. AMERICAS ALTRENOGEST MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 63. AMERICAS ALTRENOGEST MARKET SIZE, BY FEED ADDITIVE, 2018-2024 (USD MILLION)
TABLE 64. AMERICAS ALTRENOGEST MARKET SIZE, BY FEED ADDITIVE, 2025-2030 (USD MILLION)
TABLE 65. AMERICAS ALTRENOGEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 66. AMERICAS ALTRENOGEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 67. AMERICAS ALTRENOGEST MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 68. AMERICAS ALTRENOGEST MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS ALTRENOGEST MARKET SIZE, BY BREEDING FARMS, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS ALTRENOGEST MARKET SIZE, BY BREEDING FARMS, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS ALTRENOGEST MARKET SIZE, BY VETERINARY CLINICS, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS ALTRENOGEST MARKET SIZE, BY VETERINARY CLINICS, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS ALTRENOGEST MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS ALTRENOGEST MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS ALTRENOGEST MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS ALTRENOGEST MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 77. UNITED STATES ALTRENOGEST MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 78. UNITED STATES ALTRENOGEST MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 79. UNITED STATES ALTRENOGEST MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 80. UNITED STATES ALTRENOGEST MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 81. UNITED STATES ALTRENOGEST MARKET SIZE, BY FEED ADDITIVE, 2018-2024 (USD MILLION)
TABLE 82. UNITED STATES ALTRENOGEST MARKET SIZE, BY FEED ADDITIVE, 2025-2030 (USD MILLION)
TABLE 83. UNITED STATES ALTRENOGEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 84. UNITED STATES ALTRENOGEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 85. UNITED STATES ALTRENOGEST MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 86. UNITED STATES ALTRENOGEST MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 87. UNITED STATES ALTRENOGEST MARKET SIZE, BY BREEDING FARMS, 2018-2024 (USD MILLION)
TABLE 88. UNITED STATES ALTRENOGEST MARKET SIZE, BY BREEDING FARMS, 2025-2030 (USD MILLION)
TABLE 89. UNITED STATES ALTRENOGEST MARKET SIZE, BY VETERINARY CLINICS, 2018-2024 (USD MILLION)
TABLE 90. UNITED STATES ALTRENOGEST MARKET SIZE, BY VETERINARY CLINICS, 2025-2030 (USD MILLION)
TABLE 91. UNITED STATES ALTRENOGEST MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 92. UNITED STATES ALTRENOGEST MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 93. UNITED STATES ALTRENOGEST MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 94. UNITED STATES ALTRENOGEST MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 95. CANADA ALTRENOGEST MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 96. CANADA ALTRENOGEST MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 97. CANADA ALTRENOGEST MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 98. CANADA ALTRENOGEST MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 99. CANADA ALTRENOGEST MARKET SIZE, BY FEED ADDITIVE, 2018-2024 (USD MILLION)
TABLE 100. CANADA ALTRENOGEST MARKET SIZE, BY FEED ADDITIVE, 2025-2030 (USD MILLION)
TABLE 101. CANADA ALTRENOGEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 102. CANADA ALTRENOGEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 103. CANADA ALTRENOGEST MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 104. CANADA ALTRENOGEST MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 105. CANADA ALTRENOGEST MARKET SIZE, BY BREEDING FARMS, 2018-2024 (USD MILLION)
TABLE 106. CANADA ALTRENOGEST MARKET SIZE, BY BREEDING FARMS, 2025-2030 (USD MILLION)
TABLE 107. CANADA ALTRENOGEST MARKET SIZE, BY VETERINARY CLINICS, 2018-2024 (USD MILLION)
TABLE 108. CANADA ALTRENOGEST MARKET SIZE, BY VETERINARY CLINICS, 2025-2030 (USD MILLION)
TABLE 109. CANADA ALTRENOGEST MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 110. CANADA ALTRENOGEST MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 111. MEXICO ALTRENOGEST MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 112. MEXICO ALTRENOGEST MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 113. MEXICO ALTRENOGEST MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 114. MEXICO ALTRENOGEST MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 115. MEXICO ALTRENOGEST MARKET SIZE, BY FEED ADDITIVE, 2018-2024 (USD MILLION)
TABLE 116. MEXICO ALTRENOGEST MARKET SIZE, BY FEED ADDITIVE, 2025-2030 (USD MILLION)
TABLE 117. MEXICO ALTRENOGEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 118. MEXICO ALTRENOGEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 119. MEXICO ALTRENOGEST MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 120. MEXICO ALTRENOGEST MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 121. MEXICO ALTRENOGEST MARKET SIZE, BY BREEDING FARMS, 2018-2024 (USD MILLION)
TABLE 122. MEXICO ALTRENOGEST MARKET SIZE, BY BREEDING FARMS, 2025-2030 (USD MILLION)
TABLE 123. MEXICO ALTRENOGEST MARKET SIZE, BY VETERINARY CLINICS, 2018-2024 (USD MILLION)
TABLE 124. MEXICO ALTRENOGEST MARKET SIZE, BY VETERINARY CLINICS, 2025-2030 (USD MILLION)
TABLE 125. MEXICO ALTRENOGEST MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 126. MEXICO ALTRENOGEST MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 127. BRAZIL ALTRENOGEST MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 128. BRAZIL ALTRENOGEST MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 129. BRAZIL ALTRENOGEST MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 130. BRAZIL ALTRENOGEST MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 131. BRAZIL ALTRENOGEST MARKET SIZE, BY FEED ADDITIVE, 2018-2024 (USD MILLION)
TABLE 132. BRAZIL ALTRENOGEST MARKET SIZE, BY FEED ADDITIVE, 2025-2030 (USD MILLION)
TABLE 133. BRAZIL ALTRENOGEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 134. BRAZIL ALTRENOGEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 135. BRAZIL ALTRENOGEST MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 136. BRAZIL ALTRENOGEST MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 137. BRAZIL ALTRENOGEST MARKET SIZE, BY BREEDING FARMS, 2018-2024 (USD MILLION)
TABLE 138. BRAZIL ALTRENOGEST MARKET SIZE, BY BREEDING FARMS, 2025-2030 (USD MILLION)
TABLE 139. BRAZIL ALTRENOGEST MARKET SIZE, BY VETERINARY CLINICS, 2018-2024 (USD MILLION)
TABLE 140. BRAZIL ALTRENOGEST MARKET SIZE, BY VETERINARY CLINICS, 2025-2030 (USD MILLION)
TABLE 141. BRAZIL ALTRENOGEST MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 142. BRAZIL ALTRENOGEST MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 143. ARGENTINA ALTRENOGEST MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 144. ARGENTINA ALTRENOGEST MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 145. ARGENTINA ALTRENOGEST MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 146. ARGENTINA ALTRENOGEST MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 147. ARGENTINA ALTRENOGEST MARKET SIZE, BY FEED ADDITIVE, 2018-2024 (USD MILLION)
TABLE 148. ARGENTINA ALTRENOGEST MARKET SIZE, BY FEED ADDITIVE, 2025-2030 (USD MILLION)
TABLE 149. ARGENTINA ALTRENOGEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 150. ARGENTINA ALTRENOGEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 151. ARGENTINA ALTRENOGEST MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 152. ARGENTINA ALTRENOGEST MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 153. ARGENTINA ALTRENOGEST MARKET SIZE, BY BREEDING FARMS, 2018-2024 (USD MILLION)
TABLE 154. ARGENTINA ALTRENOGEST MARKET SIZE, BY BREEDING FARMS, 2025-2030 (USD MILLION)
TABLE 155. ARGENTINA ALTRENOGEST MARKET SIZE, BY VETERINARY CLINICS, 2018-2024 (USD MILLION)
TABLE 156. ARGENTINA ALTRENOGEST MARKET SIZE, BY VETERINARY CLINICS, 2025-2030 (USD MILLION)
TABLE 157. ARGENTINA ALTRENOGEST MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 158. ARGENTINA ALTRENOGEST MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA ALTRENOGEST MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA ALTRENOGEST MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA ALTRENOGEST MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA ALTRENOGEST MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA ALTRENOGEST MARKET SIZE, BY FEED ADDITIVE, 2018-2024 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA ALTRENOGEST MARKET SIZE, BY FEED ADDITIVE, 2025-2030 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA ALTRENOGEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 166. EUROPE, MIDDLE EAST & AFRICA ALTRENOGEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA ALTRENOGEST MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA ALTRENOGEST MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA ALTRENOGEST MARKET SIZE, BY BREEDING FARMS, 2018-2024 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA ALTRENOGEST MARKET SIZE, BY BREEDING FARMS, 2025-2030 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA ALTRENOGEST MARKET SIZE, BY VETERINARY CLINICS, 2018-2024 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA ALTRENOGEST MARKET SIZE, BY VETERINARY CLINICS, 2025-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA ALTRENOGEST MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA ALTRENOGEST MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA ALTRENOGEST MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA ALTRENOGEST MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 177. UNITED KINGDOM ALTRENOGEST MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 178. UNITED KINGDOM ALTRENOGEST MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 179. UNITED KINGDOM ALTRENOGEST MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 180. UNITED KINGDOM ALTRENOGEST MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 181. UNITED KINGDOM ALTRENOGEST MARKET SIZE, BY FEED ADDITIVE, 2018-2024 (USD MILLION)
TABLE 182. UNITED KINGDOM ALTRENOGEST MARKET SIZE, BY FEED ADDITIVE, 2025-2030 (USD MILLION)
TABLE 183. UNITED KINGDOM ALTRENOGEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 184. UNITED KINGDOM ALTRENOGEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 185. UNITED KINGDOM ALTRENOGEST MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 186. UNITED KINGDOM ALTRENOGEST MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 187. UNITED KINGDOM ALTRENOGEST MARKET SIZE, BY BREEDING FARMS, 2018-2024 (USD MILLION)
TABLE 188. UNITED KINGDOM ALTRENOGEST MARKET SIZE, BY BREEDING FARMS, 2025-2030 (USD MILLION)
TABLE 189. UNITED KINGDOM ALTRENOGEST MARKET SIZE, BY VETERINARY CLINICS, 2018-2024 (USD MILLION)
TABLE 190. UNITED KINGDOM ALTRENOGEST MARKET SIZE, BY VETERINARY CLINICS, 2025-2030 (USD MILLION)
TABLE 191. UNITED KINGDOM ALTRENOGEST MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 192. UNITED KINGDOM ALTRENOGEST MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 193. GERMANY ALTRENOGEST MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 194. GERMANY ALTRENOGEST MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 195. GERMANY ALTRENOGEST MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 196. GERMANY ALTRENOGEST MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 197. GERMANY ALTRENOGEST MARKET SIZE, BY FEED ADDITIVE, 2018-2024 (USD MILLION)
TABLE 198. GERMANY ALTRENOGEST MARKET SIZE, BY FEED ADDITIVE, 2025-2030 (USD MILLION)
TABLE 199. GERMANY ALTRENOGEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 200. GERMANY ALTRENOGEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 201. GERMANY ALTRENOGEST MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 202. GERMANY ALTRENOGEST MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 203. GERMANY ALTRENOGEST MARKET SIZE, BY BREEDING FARMS, 2018-2024 (USD MILLION)
TABLE 204. GERMANY ALTRENOGEST MARKET SIZE, BY BREEDING FARMS, 2025-2030 (USD MILLION)
TABLE 205. GERMANY ALTRENOGEST MARKET SIZE, BY VETERINARY CLINICS, 2018-2024 (USD MILLION)
TABLE 206. GERMANY ALTRENOGEST MARKET SIZE, BY VETERINARY CLINICS, 2025-2030 (USD MILLION)
TABLE 207. GERMANY ALTRENOGEST MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 208. GERMANY ALTRENOGEST MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 209. FRANCE ALTRENOGEST MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 210. FRANCE ALTRENOGEST MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 211. FRANCE ALTRENOGEST MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 212. FRANCE ALTRENOGEST MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 213. FRANCE ALTRENOGEST MARKET SIZE, BY FEED ADDITIVE, 2018-2024 (USD MILLION)
TABLE 214. FRANCE ALTRENOGEST MARKET SIZE, BY FEED ADDITIVE, 2025-2030 (USD MILLION)
TABLE 215. FRANCE ALTRENOGEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 216. FRANCE ALTRENOGEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 217. FRANCE ALTRENOGEST MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 218. FRANCE ALTRENOGEST MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 219. FRANCE ALTRENOGEST MARKET SIZE, BY BREEDING FARMS, 2018-2024 (USD MILLION)
TABLE 220. FRANCE ALTRENOGEST MARKET SIZE, BY BREEDING FARMS, 2025-2030 (USD MILLION)
TABLE 221. FRANCE ALTRENOGEST MARKET SIZE, BY VETERINARY CLINICS, 2018-2024 (USD MILLION)
TABLE 222. FRANCE ALTRENOGEST MARKET SIZE, BY VETERINARY CLINICS, 2025-2030 (USD MILLION)
TABLE 223. FRANCE ALTRENOGEST MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 224. FRANCE ALTRENOGEST MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 225. RUSSIA ALTRENOGEST MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 226. RUSSIA ALTRENOGEST MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 227. RUSSIA ALTRENOGEST MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 228. RUSSIA ALTRENOGEST MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 229. RUSSIA ALTRENOGEST MARKET SIZE, BY FEED ADDITIVE, 2018-2024 (USD MILLION)
TABLE 230. RUSSIA ALTRENOGEST MARKET SIZE, BY FEED ADDITIVE, 2025-2030 (USD MILLION)
TABLE 231. RUSSIA ALTRENOGEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 232. RUSSIA ALTRENOGEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 233. RUSSIA ALTRENOGEST MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 234. RUSSIA ALTRENOGEST MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 235. RUSSIA ALTRENOGEST MARKET SIZE, BY BREEDING FARMS, 2018-2024 (USD MILLION)
TABLE 236. RUSSIA ALTRENOGEST MARKET SIZE, BY BREEDING FARMS, 2025-2030 (USD MILLION)
TABLE 237. RUSSIA ALTRENOGEST MARKET SIZE, BY VETERINARY CLINICS, 2018-2024 (USD MILLION)
TABLE 238. RUSSIA ALTRENOGEST MARKET SIZE, BY VETERINARY CLINICS, 2025-2030 (USD MILLION)
TABLE 239. RUSSIA ALTRENOGEST MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 240. RUSSIA ALTRENOGEST MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 241. ITALY ALTRENOGEST MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 242. ITALY ALTRENOGEST MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 243. ITALY ALTRENOGEST MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 244. ITALY ALTRENOGEST MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 245. ITALY ALTRENOGEST MARKET SIZE, BY FEED ADDITIVE, 2018-2024 (USD MILLION)
TABLE 246. ITALY ALTRENOGEST MARKET SIZE, BY FEED ADDITIVE, 2025-2030 (USD MILLION)
TABLE 247. ITALY ALTRENOGEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 248. ITALY ALTRENOGEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 249. ITALY ALTRENOGEST MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 250. ITALY ALTRENOGEST MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 251. ITALY ALTRENOGEST MARKET SIZE, BY BREEDING FARMS, 2018-2024 (USD MILLION)
TABLE 252. ITALY ALTRENOGEST MARKET SIZE, BY BREEDING FARMS, 2025-2030 (USD MILLION)
TABLE 253. ITALY ALTRENOGEST MARKET SIZE, BY VETERINARY CLINICS, 2018-2024 (USD MILLION)
TABLE 254. ITALY ALTRENOGEST MARKET SIZE, BY VETERINARY CLINICS, 2025-2030 (USD MILLION)
TABLE 255. ITALY ALTRENOGEST MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 256. ITALY ALTRENOGEST MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 257. SPAIN ALTRENOGEST MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 258. SPAIN ALTRENOGEST MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 259. SPAIN ALTRENOGEST MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 260. SPAIN ALTRENOGEST MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 261. SPAIN ALTRENOGEST MARKET SIZE, BY FEED ADDITIVE, 2018-2024 (USD MILLION)
TABLE 262. SPAIN ALTRENOGEST MARKET SIZE, BY FEED ADDITIVE, 2025-2030 (USD MILLION)
TABLE 263. SPAIN ALTRENOGEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 264. SPAIN ALTRENOGEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 265. SPAIN ALTRENOGEST MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 266. SPAIN ALTRENOGEST MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 267. SPAIN ALTRENOGEST MARKET SIZE, BY BREEDING FARMS, 2018-2024 (USD MILLION)
TABLE 268. SPAIN ALTRENOGEST MARKET SIZE, BY BREEDING FARMS, 2025-2030 (USD MILLION)
TABLE 269. SPAIN ALTRENOGEST MARKET SIZE, BY VETERINARY CLINICS, 2018-2024 (USD MILLION)
TABLE 270. SPAIN ALTRENOGEST MARKET SIZE, BY VETERINARY CLINICS, 2025-2030 (USD MILLION)
TABLE 271. SPAIN ALTRENOGEST MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 272. SPAIN ALTRENOGEST MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 273. UNITED ARAB EMIRATES ALTRENOGEST MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 274. UNITED ARAB EMIRATES ALTRENOGEST MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 275. UNITED ARAB EMIRATES ALTRENOGEST MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 276. UNITED ARAB EMIRATES ALTRENOGEST MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 277. UNITED ARAB EMIRATES ALTRENOGEST MARKET SIZE, BY FEED ADDITIVE, 2018-2024 (USD MILLION)
TABLE 278. UNITED ARAB EMIRATES ALTRENOGEST MARKET SIZE, BY FEED ADDITIVE, 2025-2030 (USD MILLION)
TABLE 279. UNITED ARAB EMIRATES ALTRENOGEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 280. UNITED ARAB EMIRATES ALTRENOGEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 281. UNITED ARAB EMIRATES ALTRENOGEST MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 282. UNITED ARAB EMIRATES ALTRENOGEST MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 283. UNITED ARAB EMIRATES ALTRENOGEST MARKET SIZE, BY BREEDING FARMS, 2018-2024 (USD MILLION)
TABLE 284. UNITED ARAB EMIRATES ALTRENOGEST MARKET SIZE, BY BREEDING FARMS, 2025-2030 (USD MILLION)
TABLE 285. UNITED ARAB EMIRATES ALTRENOGEST MARKET SIZE, BY VETERINARY CLINICS, 2018-2024 (USD MILLION)
TABLE 286. UNITED ARAB EMIRATES ALTRENOGEST MARKET SIZE, BY VETERINARY CLINICS, 2025-2030 (USD MILLION)
TABLE 287. UNITED ARAB EMIRATES ALTRENOGEST MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 288. UNITED ARAB EMIRATES ALTRENOGEST MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 289. SAUDI ARABIA ALTRENOGEST MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 290. SAUDI ARABIA ALTRENOGEST MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 291. SAUDI ARABIA ALTRENOGEST MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 292. SAUDI ARABIA ALTRENOGEST MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 293. SAUDI ARABIA ALTRENOGEST MARKET SIZE, BY FEED ADDITIVE, 2018-2024 (USD MILLION)
TABLE 294. SAUDI ARABIA ALTRENOGEST MARKET SIZE, BY FEED ADDITIVE, 2025-2030 (USD MILLION)
TABLE 295. SAUDI ARABIA ALTRENOGEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 296. SAUDI ARABIA ALTRENOGEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 297. SAUDI ARABIA ALTRENOGEST MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 298. SAUDI ARABIA ALTRENOGEST MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 299. SAUDI ARABIA ALTRENOGEST MARKET SIZE, BY BREEDING FARMS, 2018-2024 (USD MILLION)
TABLE 300. SAUDI ARABIA ALTRENOGEST MARKET SIZE, BY BREEDING FARMS, 2025-2030 (USD MILLION)
TABLE 301. SAUDI ARABIA ALTRENOGEST MARKET SIZE, BY VETERINARY CLINICS, 2018-2024 (USD MILLION)
TABLE 302. SAUDI ARABIA ALTRENOGEST MARKET SIZE, BY VETERINARY CLINICS, 2025-2030 (USD MILLION)
TABLE 303. SAUDI ARABIA ALTRENOGEST MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 304. SAUDI ARABIA ALTRENOGEST MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 305. SOUTH AFRICA ALTRENOGEST MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 306. SOUTH AFRICA ALTRENOGEST MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 307. SOUTH AFRICA ALTRENOGEST MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 308. SOUTH AFRICA ALTRENOGEST MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 309. SOUTH AFRICA ALTRENOGEST MARKET SIZE, BY FEED ADDITIVE, 2018-2024 (USD MILLION)
TABLE 310. SOUTH AFRICA ALTRENOGEST MARKET SIZE, BY FEED ADDITIVE, 2025-2030 (USD MILLION)
TABLE 311. SOUTH AFRICA ALTRENOGEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 312. SOUTH AFRICA ALTRENOGEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 313. SOUTH AFRICA ALTRENOGEST MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 314. SOUTH AFRICA ALTRENOGEST MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 315. SOUTH AFRICA ALTRENOGEST MARKET SIZE, BY BREEDING FARMS, 2018-2024 (USD MILLION)
TABLE 316. SOUTH AFRICA ALTRENOGEST MARKET SIZE, BY BREEDING FARMS, 2025-2030 (USD MILLION)
TABLE 317. SOUTH AFRICA ALTRENOGEST MARKET SIZE, BY VETERINARY CLINICS, 2018-2024 (USD MILLION)
TABLE 318. SOUTH AFRICA ALTRENOGEST MARKET SIZE, BY VETERINARY CLINICS, 2025-2030 (USD MILLION)
TABLE 319. SOUTH AFRICA ALTRENOGEST MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 320. SOUTH AFRICA ALTRENOGEST MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 321. DENMARK ALTRENOGEST MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 322. DENMARK ALTRENOGEST MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 323. DENMARK ALTRENOGEST MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 324. DENMARK ALTRENOGEST MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 325. DENMARK ALTRENOGEST MARKET SIZE, BY FEED ADDITIVE, 2018-2024 (USD MILLION)
TABLE 326. DENMARK ALTRENOGEST MARKET SIZE, BY FEED ADDITIVE, 2025-2030 (USD MILLION)
TABLE 327. DENMARK ALTRENOGEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 328. DENMARK ALTRENOGEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 329. DENMARK ALTRENOGEST MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 330. DENMARK ALTRENOGEST MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 331. DENMARK ALTRENOGEST MARKET SIZE, BY BREEDING FARMS, 2018-2024 (USD MILLION)
TABLE 332. DENMARK ALTRENOGEST MARKET SIZE, BY BREEDING FARMS, 2025-2030 (USD MILLION)
TABLE 333. DENMARK ALTRENOGEST MARKET SIZE, BY VETERINARY CLINICS, 2018-2024 (USD MILLION)
TABLE 334. DENMARK ALTRENOGEST MARKET SIZE, BY VETERINARY CLINICS, 2025-2030 (USD MILLION)
TABLE 335. DENMARK ALTRENOGEST MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 336. DENMARK ALTRENOGEST MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 337. NETHERLANDS ALTRENOGEST MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 338. NETHERLANDS ALTRENOGEST MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 339. NETHERLANDS ALTRENOGEST MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 340. NETHERLANDS ALTRENOGEST MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 341. NETHERLANDS ALTRENOGEST MARKET SIZE, BY FEED ADDITIVE, 2018-2024 (USD MILLION)
TABLE 342. NETHERLANDS ALTRENOGEST MARKET SIZE, BY FEED ADDITIVE, 2025-2030 (USD MILLION)
TABLE 343. NETHERLANDS ALTRENOGEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 344. NETHERLANDS ALTRENOGEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 345. NETHERLANDS ALTRENOGEST MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 346. NETHERLANDS ALTRENOGEST MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 347. NETHERLANDS ALTRENOGEST MARKET SIZE, BY BREEDING FARMS, 2018-2024 (USD MILLION)
TABLE 348. NETHERLANDS ALTRENOGEST MARKET SIZE, BY BREEDING FARMS, 2025-2030 (USD MILLION)
TABLE 349. NETHERLANDS ALTRENOGEST MARKET SIZE, BY VETERINARY CLINICS, 2018-2024 (USD MILLION)
TABLE 350. NETHERLANDS ALTRENOGEST MARKET SIZE, BY VETERINARY CLINICS, 2025-2030 (USD MILLION)
TABLE 351. NETHERLANDS ALTRENOGEST MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 352. NETHERLANDS ALTRENOGEST MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 353. QATAR ALTRENOGEST MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
TABLE 354. QATAR ALTRENOGEST MARKET SIZE, BY ANIMAL TYPE, 2025-2030 (USD MILLION)
TABLE 355. QATAR ALTRENOGEST MARKET SIZE, BY PRODUCT FORM, 2018-2024 (USD MILLION)
TABLE 356. QATAR ALTRENOGEST MARKET SIZE, BY PRODUCT FORM, 2025-2030 (USD MILLION)
TABLE 357. QATAR ALTRENOGEST MARKET SIZE, BY FEED ADDITIVE, 2018-2024 (USD MILLION)
TABLE 358. QATAR ALTRENOGEST MARKET SIZE, BY FEED ADDITIVE, 2025-2030 (USD MILLION)
TABLE 359. QATAR ALTRENOGEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 360. QATAR ALTRENOGEST MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 361. QATAR ALTRENOGEST MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 362. QATAR ALTRENOGEST MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 363. QATAR ALTRENOGEST MARKET SIZE, BY BREEDING FARMS, 2018-2024 (USD MILLION)
TABLE 364. QATAR ALTRENOGEST MARKET SIZE, BY BREEDING FARMS, 2025-2030 (USD MILLION)
TABLE 365. QATAR ALTRENOGEST MARKET SIZE, BY VETERINARY CLINICS, 2018-2024 (USD MILLION)
TABLE 366. QATAR ALTRENOGEST MARKET SIZE, BY VETERINARY CLINICS, 2025-2030 (USD MILLION)
TABLE 367. QATAR ALTRENOGEST MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 368. QATAR ALTRENOGEST MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 369. FINLAND ALTRENOGEST MARKET SIZE, BY ANIMAL TYPE, 2018

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Altrenogest Market report include:
  • Merck & Co., Inc.
  • Zoetis Inc.
  • Elanco Animal Health Incorporated
  • Boehringer Ingelheim International GmbH
  • Ceva Santé Animale S.A.
  • Vetoquinol S.A.
  • Virbac S.A.
  • Norbrook Laboratories Limited
  • Dechra Pharmaceuticals PLC

Related Reports

Altrenogest Veterinary Drug Market by Animal Type (Cattle, Equine, Swine), Application (Estrus Synchronization, Reproductive Management), Form, End User, Distribution Channel - Global Forecast 2025-2030 - Product Image

Altrenogest Veterinary Drug Market by Animal Type (Cattle, Equine, Swine), Application (Estrus Synchronization, Reproductive Management), Form, End User, Distribution Channel - Global Forecast 2025-2030

  • Report
  • 190 Pages
  • Global
From
Altrenogest Oral Solution Market by Animal Type (Equine, Swine), Distribution Channel (Online Channels, Veterinary Hospitals, Veterinary Pharmacies), End User - Global Forecast 2025-2030 - Product Image

Altrenogest Oral Solution Market by Animal Type (Equine, Swine), Distribution Channel (Online Channels, Veterinary Hospitals, Veterinary Pharmacies), End User - Global Forecast 2025-2030

  • Report
  • 185 Pages
  • Global
From
Altrenogest (CAS 850-52-2) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - Product Image

Altrenogest (CAS 850-52-2) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

  • Report
  • 50 Pages
  • Global
From
Plumb's Veterinary Drug Handbook. Edition No. 10 - Product Image

Plumb's Veterinary Drug Handbook. Edition No. 10

  • Book
  • 1568 Pages
Farm Animal Services Market by Service Type (Animal Welfare Audits, Breeding Services, Disease Management), Animal Type (Aquaculture, Cattle, Poultry), Distribution Channel, Farm Size, End User - Global Forecast 2025-2030 - Product Image

Farm Animal Services Market by Service Type (Animal Welfare Audits, Breeding Services, Disease Management), Animal Type (Aquaculture, Cattle, Poultry), Distribution Channel, Farm Size, End User - Global Forecast 2025-2030

  • Report
  • 181 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.